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Almost all cases of human rabies result from dog bites, making the elimination of canine rabies a global
priority. During recent decades, many countries in the Western Hemisphere have carried out large-scale
dog vaccination campaigns, controlled their free-ranging dog populations and enforced legislation for
responsible pet ownership. This article reviews progress in eliminating canine rabies from the Western
Hemisphere. After brieﬂy summarizing the history of control efforts and describing the approaches listed
above, we note that programs in some countries have been hindered by societal attitudes and severe
economic disparities, which underlines the need to discuss measures that will be required to complete
the elimination of canine rabies throughout the region. We also note that there is a constant threat for
dog-maintained epizootics to re-occur, so as long as dog-maintained rabies “hot spots” are still present,
free-roaming dog populations remain large, herd immunity becomes low and dog-derived rabies lys-
savirus (RABLV) variants continue to circulate in close proximity to rabies-naïve dog populations. The
elimination of dog-maintained rabies will be only feasible if both dog-maintained and dog-derived
RABLV lineages and variants are permanently eliminated. This may be possible by keeping dog herd
immunity above 70% at all times, fostering sustained laboratory-based surveillance through reliable
rabies diagnosis and RABLV genetic typing in dogs, domestic animals and wildlife, as well as continuing
to educate the population on the risk of rabies transmission, prevention and responsible pet ownership.
Complete elimination of canine rabies requires permanent funding, with governments and people
committed to make it a reality. An accompanying article reviews the history and epidemiology of canine
rabies in the Western Hemisphere, beginning with its introduction during the period of European
colonization, and discusses how spillovers of viruses between dogs and various wild carnivores will
affect future eradication efforts (Velasco-Villa et al., 2017).
Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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Nearly all cases of human rabies result from dog bites. During
recent decades, many countries in the Western Hemisphere have
markedly reduced the incidence of human rabies by carrying out
large-scale dog vaccination campaigns, controlling free-ranging
dog populations and enforcing legislation for responsible pet
ownership, as well as providing rabies postexposure prophylaxis
(Schneider et al., 2007). As a consequence, the annual incidence of
human rabies has been reduced almost to zero in North America,
and the number of cases in Central and South America and the
Caribbean has markedly decreased (Vigilato et al., 2013).
In this article, we review progress in eliminating canine rabies
from the Western Hemisphere. After brieﬂy summarizing the his-
tory of canine rabies control and describing successful programs,
we note that elimination efforts in a small number of countries
continue to be hindered by societal attitudes and severe economic
disparities. We then explain how the achievement of hemisphere-
wide eradication will require supplementing the three strategies
listed above with other mechanisms, including wider education of
the public on the prevention of rabies transmission, the creation ofTable 1
Major rabies reservoir hosts in the Western Hemisphere.
Reservoir host common
name
Virus variant common name (reservoir host species)
Bat-maintained rabies virus variants
New World bats Nearly 30 rabies virus variants in more than 20 different ba
species
Bat-related rabies virus variants
Raccoons Raccoon variant (Procyon lotor)
Skunks South-central skunk variant (Mephitis mephitis)and
North-central skunk Mexico variant (Spilogale putorious)
Marmoset Sagui/marmoset variant (Callithrix jacchus)
Kinkaju Chosna/Kinkajou variant (Potos ﬂavus)
Dog-maintained rabies virus variants
Dogs Dog lineages from speciﬁc countries
Dog-related rabies virus variants
Grey fox Texas gray fox variant (Urocyon cinereoargenteus)
Grey fox Arizona gray fox variant (Urocyon cinereoargenteus)
Crab-eating fox Crab-eating fox variant (Cerdocyon thous)
Peruvian fox Peruvian fox variant (Lycalopex sechurae)
Striped skunk California skunk variant (Mephitis mephitis)
Striped skunk Sinaloa, Durango, Sonora skunk variant (Mephitis mephitis
Spotted skunk Baja California Sur Mexico (Spilogale putorious lucasana)
Coyote Coyote/dog variant (Canis latrans)
Mongoose Mongoose/dog variant (Herpestes javanicus)
Arctic fox Arctic fox variant (Vulpes lagopus)decentralized networks for animal control and enhanced
laboratory-based surveillance. An accompanying article reviews
the history and epidemiology of canine rabies in the Western
Hemisphere, beginning with its introduction during the period of
European colonization, and discusses how spillovers of viruses
between dogs and various wild carnivores will affect future eradi-
cation efforts (Velasco-Villa et al., 2017).2. Background: rabies in the Western Hemisphere
Rabies is an acute encephalomyelitis caused by viruses in the
genus Lyssavirus of the family Rhabdoviridae. Rabies lyssavirus
(RABLV), the prototype species of the genus, causes disease in
nearly all terrestrial mammals. Despite the worldwide distribution
of RABLV, only a few animal species in the orders Carnivora, Chi-
roptera and Primates play a critical role in maintaining the circu-
lation of the virus in nature. Most of these mammals harbor
species-speciﬁc RABLV variants which circulate within discrete
geographic boundaries (Table 1). However, because almost all cases
of human rabies result from the bites of rabid dogs, dog-maintained
viruses are by far the most important target of control measures.Geographic range Frequency of human infections
t All Western Hemisphere Rare
Eastern United States and Southeast and
Central Canada
Rare
South-central U. S. and North-central Mexico Rare
Northeastern Brazil Rare
Peru (Amazon region) Never reported
Marginal distribution across Latin America
and the Caribbean
Common in rabies hot spots
Texas (extinct) Never reported
Arizona, New Mexico, Texas and Northwest
Mexico
Rare
Northeastern Brazil Rare
Northwestern Peru Never reported
California U. S. Never reported
) Northwestern Mexico Rare
Baja California Sur Mexico Rare
South Eastern U. S (extinct), North Eastern
Mexico (likely present)
Once reported
Caribbean Common
Alaska, Canada, Greenland Once reported
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et al., 2017), historical records and phylogenetic analysis of viral
sequences indicate that the introduction and establishment of
rabies in domestic dogs and some wild mesocarnivores in the
Western Hemisphere occurred after massive European colonization
events (Smith et al., 1992; Lucas et al., 2008). Since then, different
lineages of RABLV circulating within dog populations have recur-
rently spilled over and caused disease in awide range of susceptible
mammals. These sporadic epizootics have been the source for
subsequent establishment of dog-maintained RABLV lineages in a
number of species of wild terrestrial mesocarnivores such as
skunks, foxes, coyotes and mongooses, giving rise to different dog-
derived RABLV variants throughout the Americas (Carnieli et al.,
2008; Smith, 1989; Velasco-Villa et al., 2008). The establishment
of dog-derived RABLV lineages in wildlife seems to be reservoir-
speciﬁc, and lineages are maintained in geographically deﬁned
enzootic regions (Table 1).
Current surveillance reports in the USA have identiﬁed the
geographic distribution of major independent enzootics associ-
ated with these different terrestrial carnivore species and their
respective RABLV variants (Monroe et al., 2016). Thus, a dog-
maintained RABLV lineage is operationally deﬁned as a virus
that is perpetuated between ill and healthy dogs exclusively. In
contrast, a dog-derived RABLV variant is a formerly dog-
maintained lineage that has spilled over and become established
within a speciﬁc population of wild terrestrial mesocarnivores, inTable 2
Major milestone events for the gradual elimination of dog-speciﬁc RABLV lineages from th
dogs infected with dog-speciﬁc RABLV variants: SIRVERA/SIEPI-PANAFTOSA/OPS-OMS (up
gramas de Rabia de las Americas), from its acronym in Spanish.
Period Milestone events, in chronological order
1888-early 1900's Beginning of rabies vaccination in humans with Semple's ty
1960e1979 Production of suckling-mouse-brain vaccine.
Availability of PEP for humans in large cities.
Vaccination campaigns of owned dogs in large cities.
Dog population management by removal of stray dogs in ca
Introduction of rabies diagnostic units in major cities, based
staining).
Implementation of direct immunoﬂuorescent antibody test
laboratories only.
1980e1990 Dog rabies is recognized as a public health problem
PAHO/WHO advocates and coordinates rabies control and p
REDIPRA
Creation of multifunctional anti-rabies centers in major citie
1991e2015 Establishment of comprehensive national rabies control and
humans, administered by Ministries of Health with federal b
Acquisition of cell culture-derived rabies vaccines for huma
Implementation of a revolving fund administered by PAHO
expenses of cold chain storage
Execution of massive dog vaccination campaigns with interse
twice a year.
Establishment of minimum potency policies for human and a
to counteract adverse cold chain and ﬁeld conditions
Implementation of regional ﬁnancial strategies (PAHO revol
acquisition of rabies biologicals for humans and animals at m
Creation of decentralized nationwide rabies diagnostic netw
Improvement of cold chain for human and animal vaccines a
levels
Creation of decentralized nation-wide animal control Units
Legislation and enforcement of responsible pet ownership
Embrace policies for elimination and management of stray d
with NGOs, humane societies and the community.
Communication outreach sponsored by Ministries of Health
intersectoral collaboration.
Technology transfer agreements with WHO collaborating ce
laboratory-based rabies surveillance.
Implementation of oral rabies vaccination for free-roaming
maintaining dog-speciﬁc and dog-related RABV.which rabies transmission cycles become independently
perpetuated.
As discussed in the companion paper, novel dog-derived RABLV
variants may be sporadically implicated in spillover infections into
other susceptible mammals, causing epizootics with limited dura-
tion and extension (Smith, 1989; Monroe et al., 2016). However,
there is a continuing risk that these variants could become re-
established in unvaccinated dog populations, since spillovers
from wildlife into unvaccinated dogs are common in rural areas
(Velasco-Villa et al., 2008). Some current examples of dog-derived
RABLV variants and their potential impact on the elimination of
canine rabies will be addressed further in this review.
3. Regional control efforts and lessons learned
Efforts at rabies control and prevention in the Americas date
back to the time of Louis Pasteur's vaccine studies. In 1888, three
years after the ﬁrst human vaccination against rabies in France,
brains of rabbits infected with RABLV were brought to Mexico City
by Dr Eduardo Liceaga, who initiated the ﬁrst efforts at human
rabies prevention in Latin America (Table 2) (Rodríguez de Romo,
1996; Lucas et al., 2008).
Canada and the USAwere the ﬁrst countries of the Americas to
make signiﬁcant advances in the control and elimination of dog-
maintained RABLV variants from their dog populations. From
the 1940s to the late 1950s, most of the sporadic dog rabieseWestern Hemisphere. ND: not determined. Source for the numbers of humans and
dated to 2015) http://siepi.panaftosa.org.br/. REDIPRA (Reunion de Directores de Pro-
Impact on conﬁrmed rabies
Cases in dogs Cases in humans
pe vaccines. ND ND
1960s: ND
1979: 23000
1960s: ND
1979: 310
pital cities.
on histopathology (Seller's
(DFA) in national reference
1980: 24000
1990: 8500
1980: 300
1990: 270revention initiatives throughout
s.
prevention programs for dogs and
udget.
1991: 16250
2015: 316
1991: 240
2015: 3
ns and animals
to acquire rabies biologics a cover
ctoral and community cooperation
nimal rabies vaccine manufactures
ving fund) for consolidated
ore affordable prices
orks, using DFA as gold standard.
t Federal, State, Municipal and local
og populations in collaboration
and the federal government, with
nters on rabies to strengthen
dogs and wildlife species
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over from the arctic fox RABLV variant into sled dogs, particularly
in northern regions of the country (Johnson, 1971). During this
time, control of rabies in the USA and Mexico became more
problematic due to the greater diversity of dog-maintained and
dog-derived RABLVs circulating in both countries and the implicit
challenges associated with coordination of bi-national efforts
(Velasco-Villa et al., 2008). The USA attained elimination of all
dog-maintained lineages and the dog/coyote RABLV variant by
2007 (Sidwa et al., 2005). The dog/coyote RABLV variant was the
ﬁrst dog-derived RABLV eliminated from a territory in the West-
ern Hemisphere by means of oral vaccination of coyotes (Slate
et al., 2009).
In 1954, Eduardo Fuenzalida and Raul Palacios made possible
low-cost domestic production of vaccines that were later used for
both human rabies postexposure prophylaxis (PEP) and vaccination
of dogs. This beta-propiolactone fully-inactivated vaccine with low
myelin content was ﬁrst licensed for use in humans in Chile in 1960,
and later adopted by Uruguay for human PEP in 1963, followed by
Argentina and Peru in 1964, Brazil and Venezuela in 1965, Cuba and
Mexico in 1967, and Ecuador and Guatemala in 1969 (PAHO, 2010).
Mexico was one of the ﬁrst countries in Latin America to implement
large-scale vaccination of dogs against rabies in preparation for the
1968 Olympic Games inMexico City. The Fuenzalida-Palacios vaccine
and a live attenuated cell-culture vaccine of chick-embryo origin
(CEO), commercially available at that time, were used for this
campaign (Lucas et al., 2008; Steele,1988; Secretaria de Salud, 2001).
As the commercial and domestic production of cell culture-
derived live-attenuated and fully inactivated Fuenzalida-Palacios
vaccines increased in the early 1970's, sporadic efforts to carry
out mass vaccination of dogs were expanded to other large Latin
American capitals, such as Buenos Aires, Argentina, Lima, Peru and
several major cities in Mexico. (Lucas et al., 2008; Navarro et al.,
2007). In 1970, Mexico vaccinated more than 200,000 dogs, and
by the end of that decade mass vaccinations of dogs, mostly with
the CEO vaccine, reached over a million doses a year. However,
despite these massive vaccination efforts, dog and human rabies
cases did not decrease signiﬁcantly during the period 1970e1989.
In this 20-year period, Mexico reported a total of 1430 cases in
humans and nearly 76,000 in dogs. The number of vaccine doses
applied per year in the dog population continued to increase as the
numbers of humans and dogs exploded and more commercially
produced fully inactivated cell-culture derived vaccines became
available.
In 1989, Mexico replaced the use of live-attenuated vaccines
with more potent inactivated cell-culture-derived canine vac-
cines. In the same year, the number dog vaccinations in Mexico
was above 5 million doses a year, which increased to 15 million
doses by 2005. Consistency in dog vaccination coverage has been
kept stable since 2005, reaching nearly 16 million doses admin-
istered during “the rabies vaccination week” in 2015. The shift to
fully inactivated cell-culture vaccines, together with the dramatic
increase in vaccination coverage (and some other important ac-
tions) translated into a steep decrease in the number of dog rabies
cases, from 3049 in 1990 to 6 in 2015, and human infections went
from 60 to 0 in the same period (Secretaria de Salud, 2001;
Secretaria de Salud, 2016).
A critical milestone in the implementation of sustainable rabies
control and prevention programs in Latin America was the political
recognition of canine rabies as a human public health problem,
which resulted in the transfer of all rabies control and prevention
activities to ministries of health. Previously, rabies control in dogs
had been strictly coordinated and funded by ministries of agricul-
ture in most Latin American countries. The new initiative guaran-
teed sustained budgets for all activities related to rabies control andprevention in dogs, such as mass vaccination, creation and main-
tenance of a diagnostic infrastructure, construction of anti-rabies
centers, support for dog population control activities and educa-
tional outreach (Table 2) (Schneider et al., 2007; Lucas et al., 2008).
In 1983, this initiative was actively disseminated and later estab-
lished as a political commitment through Pan American Health
Organization/World Health Organization (PAHO/WHO) member
countries. Periodic meetings coordinated by PAHO (called REDIPRA
from its acronym in Spanish) gathered all Directors of National
Rabies Programs to follow up on progress made and address
ongoing challenges (Table 2) (Belotto et al., 2005; Schneider et al.,
2007).
Early attempts at laboratory-based surveillance were made
through the diagnosis of rabies in humans and animals by
laboratory-based testing that began between 1960 and 1979.
Seller's staining of dog brain tissue predominated as the method of
choice for rabies diagnosis during that period, but this test had low
speciﬁcity, low sensitivity and required an experienced pathologist.
The current gold-standard for rabies diagnosis worldwide is the
direct immune-ﬂuorescent antibody test (DFA), which was ﬁrst
employed in 1958 and has been widely used in Latin America since
the early 1980s (Table 2) (Schneider et al., 2007; Orciari and
Rupprecht, 2011). This period was also remarkable for the crea-
tion of multifunctional anti-rabies centers inmajor urban areas that
were equipped with veterinarians and quarantine facilities, where
suspicious rabid dogs were assessed and euthanized, and brain
samples were taken for submission to rabies diagnostic labs. Vac-
cinations for owned dogs were also provided free of charge. These
centers were mostly funded by local, state and municipal govern-
ments during this period (Table 2) (Belotto, 1988; Steele, 1988;
Lucas et al., 2008; Navarro et al., 2007).
4. Current status of the elimination of dog-maintained RABLV
variants from dog populations in Latin America
In the period from 2005 to 2015, a 98% reduction in rabies cases
in dogs contributed to a 96% reduction in human rabies (Fig. 1,
Table 3). These remarkable efforts have reduced the human rabies
burden in Latin America, from 285 cases in 1970 to 3 in 2015 (Figs. 1
and 2, Table 3). During the decade 2005e2015, 139 human cases of
rabies transmitted by dogs were reported in the region, with peaks
in 2006 (30 cases) and 2011 (24 cases). Haiti and Bolivia reported
the largest number of human rabies cases transmitted by dogs, with
38 and 29 cases respectively (Fig. 1). Nonetheless, rabies burden in
humans in this countries may be likely underreported (Fig. 1,
Table 3).
A more dramatic impact of these achievements can be best
observed with cumulative ﬁgures published within the period
1970e1983, when 224,689 cases in dogs and 3662 cases in humans
were reported for only the major cities of Mexico, Guatemala,
Honduras, El Salvador, Colombia, Venezuela, Ecuador, Peru, Bolivia,
Brazil and Argentina (Steele, 1988). The contemporary persistence
of dog and human rabies in some countries of the region is caused
by great economic disparities that hinder the regular acquisition of
dog and human rabies vaccines, as well as by severe logistic con-
straints to deliver such vaccines to target populations (Figs. 1 and 2,
Table 3) (Schneider et al., 2007; PAHO, 2010).
The signiﬁcant reduction of human rabies cases associated with
dogs is causing a shift in laboratory-based rabies surveillance to
wildlife (bats and mesocarnivores), which is revealing long-term
RABLV circulation in previously unnoticed wild reservoir hosts
(Fig. 3) (Schneider et al., 2007; Vigilato et al., 2013). Nonetheless,
under current laboratory-based rabies surveillance conditions, it
remains challenging to ascertain the elimination status of dog-
maintained RABLV variants in some countries of Latin America
Fig. 1. Distribution of dog-maintained rabies and its impact on rabies in humans transmitted from dogs in Latin America and the Caribbean. Solid red circles depict the total number
of human rabies cases from 1993 to 2015; the size of each circle represents the number of cases according to the scale (lower left). Grayscale of countries represents the number of
laboratory-conﬁrmed rabid dogs carrying dog-maintained RABLV variants from 1993 to 2015. Scale for number of cases is depicted in the lower left. Countries with no cases or no
data available are in white. Source, SIRVERA/SIEPI-PANAFTOSA/PAHO/WHO, http://new.paho.org/panaftosa. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
A. Velasco-Villa et al. / Antiviral Research 143 (2017) 1e12 5(Fig. 4). Several countries continue to report rabies transmitted by
dog exposures or the occurrence of rabies in dogs, but without the
laboratory capacity to perform RABLV variant typing (Table 3).Table 3
Countries of Latin America and the Caribbean that have reported cases of human rabies tr
PAHO during 2005e2012. A: Countries reporting laboratory-conﬁrmed rabies cases in d
include Chile, Costa Rica, Ecuador, Panama, Paraguay, and Uruguay, which have reported n
surveillance network, conducting RABLV variant typing on a regular basis, this category
typing Costa Rica, Ecuador, Nicaragua, Panama, Uruguay and Paraguay do not have enoug
maintained RABLV lineages. Furthermore, these countries have neighboring territories w
incidence was available for Belize, Guyana, and Suriname due to a lack of active laborator
supporting absence of canine rabies from the island till 2013. Source: SIRVERA/SIEPI-PAN
Country Notes 2005 2006 2007 2008 20
Argentina A, B 1
Bolivia A, B 8 4 4 4 3
Brazil A, B 1 6 1 2
Colombia A, B 2 2
Cuba A 1 2
Dominican Republic A 1 3
El Salvador A, C 2 2 1
Guatemala A, C 1 1 1 3 3
Haiti 1 11 6 4
Honduras A, C 1
Mexico A, B 2
Peru A, B 2 2
Venezuela C 1 1Variant typing is necessary to understand the origin of the virus
and its associated reservoir host in any particular case (Table 3,
Fig. 3). If an alternative variant is not identiﬁed or demonstrated,ansmitted by dogs and circulation of dog-maintained RABLV lineages, as reported to
ogs, humans, livestock, and wildlife to PAHO on a monthly basis, this category also
o cases in the last decade. B: Countries with a decentralized laboratory-based rabies
also includes Chile. Notes: 1. As for laboratory based surveillance coverage and viral
h laboratory-based evidence to objectively assessed the presence or absence of dog-
ith conﬁrmed enzootic dog-maintained RABLV lineages. 2. No information on rabies
y based surveillance. 3. Trinidad & Tobago recently published a retrospective report
AFTOSA/OPS-OMS (2005e2015).
09 2010 2011 2012 2013 2014 2015 Total
1
5 1 2 29
1 2 2 3 1 19
4
3
3 2 2 2 13
5
3 12
1 13 2 ? 38
1 2
2
1 1 2 1 9
2
Table 4
Enhanced laboratory-based surveillance: countries of the Americas with the largest
number of samples processed in a year. CDC, SIRVERA/SIEPI-PANAFTOSA/OPS/OMS,
2012.
Country Number of laboratories
in the network
Number of samples
processed
Argentina 11 2600
Brazil 37 30000
Colombia 12 2700
Mexico 29 11000
Peru 21 10000
United States 125 125000
A. Velasco-Villa et al. / Antiviral Research 143 (2017) 1e126the presence or absence of dog-maintained variants cannot be
veriﬁed and elimination status cannot be determined. This problem
underscores the need for enhanced laboratory-based surveillance
networks with viral typing capabilities (Figs. 3 and 4).Fig. 2. Canine rabies elimination efforts in Latin America and the Caribbean. Geographic lo
oratories in the period 2010e15.The continued circulation of dog-maintained RABLV variants in
the dog populations of semirural and irregular settings threatens
progress toward elimination, and has caused sporadic outbreaks in
dogs, humans, and wildlife in border areas of Argentina, Bolivia,
Brazil, Colombia, Cuba, Dominican Republic, El Salvador, Ecuador,
Guatemala, Haiti, Honduras, Mexico, Nicaragua, Peru and
Venezuela, where elimination had apparently been achieved (Fig. 2,
Table 3). Delimited areas within these countries have been identi-
ﬁed by PAHO as rabies “hot-spots”, due to the persistence of dog-
maintained RABLV cases related with continued viral circulation
over the past 6 years. As noted, these apparent setbacks are the
result of great economic, health and cultural disparities, which
continue to pose major challenges to the control and eventual
elimination of dog-maintained rabies. These persistent hot spots
are geographically remote with difﬁcult access by land, living
conditions are extremely poor, free-roaming dog populations are
large, rabies herd immunity is low and national mass vaccinationcation of dog-maintained rabies foci, as conﬁrmed by PAHO collaborating center lab-
Fig. 3. Laboratory-conﬁrmed infections with dog-derived RABLV variants in humans and animals that were acquired from carnivore species other than dogs from 2005 to 15.
Grayscale reﬂects the number of conﬁrmed human cases in which dog-derived variants transmitted by cats and wild carnivore hosts were identiﬁed. (Cats are not reservoir hosts,
but can be involved as secondary transmitters of rabies.) Countries that did not report cases during this time period (Chile, Argentina, Guatemala, Costa Rica, El Salvador and
Panama) and those with no data available or that do not report to PAHO (Trinidad and Tobago, Guyana, Surinam, and French Guiana) are shown in white. Colored bars within
countries depict the most frequently positive species and major transmitters to humans, with cats (red), foxes (blue), skunks (yellow), and mongoose (green). Source, SIRVERA/
SIEPI-PANAFTOSA/PAHO/WHO, http://new.paho.org/panaftosa. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of
this article.)
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2007; Vigilato et al., 2013).
Surveillance approaches in countries such as Costa Rica, Belize,
Nicaragua, Panama, Paraguay, Surinam and Uruguay, do not allow
for the accurate assessment of the status of enzootic dog-
maintained RABLV elimination (Figs. 1 and 3, Table 3). These
countries frequently report rabies in livestock, but do not conduct
RABLV typing on a regular basis, despite having neighboring
countries with enzootic dog-maintained RABLV (Figs. 1 and 2). In
contrast, the situation on island countries such as Trinidad and
Tobago that have not reported circulation of enzootic dog-
maintained RABLV variants since the 1950's may be radically
different. To stress the importance of viral typing, recent studies
have implicated enzootic vampire bat-speciﬁc RABLV variants inspillover events occurring in susceptible animals (including dogs)
of these islands (Seetahal et al., 2013; Wright et al., 2002).
Canada and the USA, through their PAHO/WHO rabies research
reference centers [the Canadian Food Inspection Agency (CFIA) and
the U. S. Centers for Disease Control and Prevention (CDC)] and in
conjunction with other government institutions, collaborate with
countries of Latin America and the Caribbean to support regional
capacities for laboratory-based surveillance, to expedite rabies
detection, and to support reference activities such as antigenic and
genetic typing of RABLV for identiﬁcation of variants and most
likely transmission sources. In addition, regional political agree-
ments such as the North American RabiesManagement Plan among
Canada, the USA and Mexico, signed in 2008, which provide con-
tinuity for canine rabies elimination efforts in the region (Slate
Fig. 4. Distribution of rabies diagnostic laboratories in Latin America and the Caribbean, their capacity and their afﬁliation to a Ministry of Health or Ministry of Agriculture. Color-
coded countries represent total human rabies cases reported, as a reﬂection of testing capacity. Countries with low numbers of cases are in blue, medium in pink, and high in red.
Countries with no cases reported or no data available are shown in white. Laboratory diagnostic capacity is depicted as follows: green dots for countries performing the “gold
standard” direct ﬂuorescent antibody test (DFA), ﬁlled black squares for countries performing DFA and viral typing by monoclonal antibodies and/or sequencing techniques (typing),
and gold stars for countries performing DFA, viral typing and antibody titration via rapid immune ﬂuorescent foci inhibition test (RIFFT). Countries with two icons (dot and square)
represent independent diagnostic capacities for laboratories of the Ministry of Health and the Ministry of Agriculture. The locations of the icons represent the actual geographic
locations of the labs. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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technology, expedites typing results through CDC and CFIA, pro-
vides regular training on existing or novel diagnostic and typing
technologies, supplies and replenishes diagnostic/virus typing kits
and reagents on a regular basis, and promotes the periodic ex-
change of relevant rabies epidemiological and epizootiological in-
formation (Slate et al., 2009).
The implementation and reﬁnement of rabies control and pre-
vention strategies in Latin America have been remarkably
enhanced by introducing objective indicators tomonitor circulation
of dog-maintained RABLV, such as typing technologies that include
sequencing, coupled with phylogenetic analysis and antigenic
typing with panels of monoclonal antibodies (Orciari and
Rupprecht, 2011). These techniques provide information on viral
variants or lineages linked with speciﬁc reservoir hosts (Smith,
1989; Smith et al., 1992). The identiﬁcation of a reservoir host
helps to implement speciﬁc control and prevention measures, as
well as allowing the expeditious detection of importation events
(Rupprecht et al., 2008).5. Foundation of a national program of rabies control and
prevention
The strategic designation of human health ministries as the
administrative entities responsible for rabies control and pre-
vention programs constituted a key political breakthrough to
move forward the elimination of dog-maintained rabies in Latin
America (Schneider et al., 2007). This initiative provided the
funding to:
 maintain adequate vaccine stocks for the immunization of
humans and animals at no cost;
 construct a decentralized network for animal control, surveil-
lance and vaccination, which will be also responsible for col-
lecting and submitting samples to diagnostic laboratories;
 build a decentralized rdiagnostic laboratory network to support
surveillance and expedite local control and prevention;
 organize educational outreach programs to promote awareness
for rabies control and prevention.
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tiveness of a national program (Belotto et al., 2005; Lucas et al.,
2008).
6. Implementation of nationwide dog vaccination campaigns
In the early 1990's, mass dog vaccination campaigns were
implemented across the continental Americas and the Caribbean in
countries including Mexico, Guatemala, Honduras, Dominican Re-
public, Cuba, Colombia, Ecuador, Peru, Chile, Argentina and Brazil
(Belotto, 1988; Chomel et al., 1988; Navarro et al., 2007; Schneider
et al., 2007; Lucas et al., 2008; Suzuki et al., 2008; PAHO, 2010).
These campaigns varied in the extent of geographic coverage, the
proportion of the dog population vaccinated, the types of vaccines
used (cell culture-derived vaccines being signiﬁcantly more potent
than nerve tissue-derived vaccines), and the assessment of their
impact (Table 2, Fig. 2).
The different approaches had a direct effect on the pace at which
the incidence of rabies was reduced in dogs and indirectly in
humans (Belotto et al., 2005; Schneider et al., 2007). Through 2015,
Brazil and the Dominican Republic reported dog-maintained RABLV
variant in humans (1 and 2 cases, respectively). The data do not
include Haiti, because it does not have an adequate laboratory-
based surveillance system; however, there is known to be an
ongoing dog rabies epizootic, and living conditions are of extreme
poverty (Table 3, Fig. 2) (PAHO, 2010). The struggles of these three
countries reiterate substantial differences in economic capacities,
size, cultural idiosyncrasies, rabies control and prevention strate-
gies (types of vaccines used, government entity that runs the rabies
program, and available overall infrastructure to obtain and deliver
samples to diagnostic labs), human and dog population de-
mographics, circulation of dog-maintained lineages in rural dog
populations and public health priorities (Belotto et al., 2005;
Schneider et al., 2007).
To ensure vaccine availability and affordability for both dogs and
humans, several countries have engaged in a revolving fund, in
which PAHO serves as manager and negotiator of consolidated
purchases of rabies biologics with manufacturers (Schneider et al.,
2007; Vigilato et al., 2013). All participating countries contribute
3.5% of their projected net purchase price for vaccine to create a
common fund that will serve as negotiation capital with manu-
facturer companies of rabies biologics. Three percent of the fund is
used entirely as working capital to offer a line of credit to partici-
pating countries that may require it, and 0.5% is used to cover the
administrative costs of purchasing activities. Such lines of credit
enable member countries that lack liquidity at the time of the
purchase to acquire vaccine or rabies biologics and pay the
revolving fund within 60 days of receipt. The revolving fund has
been an essential factor in making the Americas a global role model
for the success of immunization programs, the introduction of new
vaccines and the signiﬁcant reduction of health disparities within
the region (PAHO and WHO, 2014).
7. Supplementary strategies to increase coverage of mass dog
vaccination campaigns
Dog population management critically impacts efforts to ach-
ieve sustained rabies herd immunity within a population (Lembo
et al., 2012). Current practices in Latin America predominantly
employ surgical spaying and neutering in animal control units or
itinerant surgeries during mass vaccination campaigns. Culling has
been practiced occasionally as a desperate measure to stop epizo-
otics involving high numbers of human exposures.
Alternatively, hormone-based vaccine-induced contraception
methods seem to be promising choices for stabilizing free-roamingdog populations in Latin American countries (Lucas et al., 2008;
Smith et al., 2011; Wu et al., 2009). Parenteral or hand-out de-
livery methods for these types of formulations seem to be safe
choices to reach owned-dog populations, but may be impractical in
the medium- and long-term to reach free-roaming dogs. Oral vac-
cines with contraceptive activity need to be further characterized to
ensure that non-target species will not be affected by their use,
especially if they are distributed in oral formulations and delivered
in the same fashion as for wildlife and their contraceptive
component works for a wide spectrum of species. The concomitant
administration of rabies parenteral vaccine and an immune-
contraceptive vaccine has also been attempted in an effort to
both manage populations and immunize against rabies. More
research is needed to prove the efﬁcacy, safety and practicality of
such approaches in the ﬁeld (Vargas-Pino et al., 2013; Wu et al.,
2009).
Utilization of more potent canine vaccines, such as cell culture-
derived vaccines (with 2 or more international units per dose), has
provided an additional means of expanding dog vaccination
coverage. An optimal vaccine for delivery under ﬁeld conditions
should be potent and stable, to withstand transportation to remote
locationswhere an efﬁcient cold chain is lacking (Lucas et al., 2008).
Recently, most countries of Latin America have transitioned from
nerve tissue-derived vaccines to cell culture-derived vaccines for
both dogs and humans, because of side effects affecting the central
nervous system of the target species, and because fully inactivated
cell culture-derived preparations are signiﬁcantly more potent
(National Association of State Public Health Veterinarians
Committee, 2008; Smith et al., 2011). Alternatively, some coun-
tries have instituted minimum potency requirements in their pur-
chasing and acquisition policies, as a means to ensure that the
vaccine will adequately immunize dogs when used in the ﬁeld,
even if cold-chain conditions are not ideal. Recently, thermotoler-
ant and thermostable vaccine formulations seem to be an excellent
alternative to overcome cold-chain constraints and to expand
coverage with acceptable immunization results (Lankester et al.,
2016; Smith et al., 2015).
Oral vaccination may become an alternative to vaccinate free-
roaming dog populations to increase coverage in places that are
virtually impossible to reach through mass parenteral vaccination
campaigns. However, no country in Latin America has engaged
consistently in such activity, because it requires a more complex
logistical apparatus and a more expensive vaccine (Corn et al.,
2003). More recent vaccine developments implicate the use of
genetically modiﬁed (reverse genetics), highly immunogenic and
attenuated ﬁxed rabies virus constructs that are also capable of
expressing a contraceptive component. What these new generation
vaccines are pursuing is a drastic reduction in production and de-
livery costs (for their single dose efﬁcacy) as well as making more
affordable, accessible and efﬁcient dog population control. More
investment, research and policy changes are needed to make
feasible the application of these novel tools (Huang et al., 2015; Li
et al., 2012; Wu et al., 2009).
8. Legislation and law enforcement of responsible dog
ownership
Local and nationwide laws for responsible pet ownership and
their adequate enforcement are paramount for maintaining a
healthy dog population, which consequently reduces the risk of
transmission of zoonotic diseases to humans (National Association
of State Public Health Veterinarians Committee, 2008). Enforce-
ment requires cooperation and action among all levels of govern-
ment in Latin American countries, together with nonproﬁt
organizations, local humane societies and pet owners.
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Current practices to assess rabies vaccination coverage in Latin
America compare the number of vaccinated dogs (based on vacci-
nation certiﬁcates issued, vaccination collars/tags used or verbal
conﬁrmation by owners after surveys) to estimate dog populations
(Alves et al., 2005; Flores-Ibarra and Estrella-Valenzuela, 2004;
Suzuki et al., 2008). However, this approach has some implicit
biases if free-roaming or feral dog populations are not counted,
particularly because they constitute the most important segment of
the dog population in the maintenance of dog-maintained RABLV
(Wandeler et al., 1988).
More effectivemethods that have not been fully implemented in
Latin America include random samplings with mark-and-release
strategies, in which serum samples are taken from some dogs to
measure rabies-speciﬁc antibodies as evidence of vaccination
(Chomel et al., 1988; Suzuki et al., 2008; Wandeler et al., 1988). A
mark-resight survey of dogs temporarily marked during vaccina-
tion campaigns is another way of estimating vaccination coverage
and a rough estimate of the dog population (Conan et al., 2015).
Although such methods are more expensive to implement, their
long-term beneﬁts for improved vaccination strategies and better
administration of available resources make them more cost-
effective (Lembo et al., 2012).
10. Role of laboratory-based surveillance networks and
animal control units
To enhance laboratory-based surveillance coverage and
harmonize the standardized use of diagnostic techniques in the
Americas, representatives of rabies reference laboratories from the
Ministries of Agriculture and Health of Argentina, Bolivia, Brazil,
Colombia, Chile, Costa Rica, Cuba, Dominican Republic, Ecuador, El
Salvador, Guatemala, Haiti, Honduras, Mexico, Nicaragua, Panama,
Paraguay, Peru, Trinidad and Tobago, Uruguay and Venezuela met
in September, 2011, for the ﬁrst joint conference of human and
animal health laboratories to strengthen national capacities for the
diagnosis and surveillance of urban and wildlife rabies. Based on
the extent of territorial coverage of their diagnostic laboratory
networks and the annual number of samples processed, the
countries with the greatest number of samples tested in one year
are Argentina, Brazil, Colombia, Mexico and Peru (Table 4) (CDC,
SIRVERA/SIEPI-PANAFTOSA/OPS/OMS, 2012).
The signiﬁcance of the number of laboratories and the total
numbers of samples processed represents to some extent the level
of conﬁdence for a country to validate its rabies-free status, as
regards the circulation of dog-maintained RABLV lineages. More-
over, these indicators may be also linked with laboratory-based
sensitive approaches for the detection of imported dog-
maintained RABLV lineages that may jeopardize rabies-free status
(Fig. 4). A suitable laboratory based-surveillance system should
provide comprehensive territorial coverage (including all rabies
“hot spots”) and be based on standardized laboratory diagnostic
techniques for detection of RABLV antigen, including the “gold-
standard” DFA, antibody titration by the rapid ﬂuorescent-focus
inhibition test (RFFIT), indirect ﬂuorescent antibody test (IFA) and
RABLV RNA detection via reverse transcription PCR assays (Orciari
and Rupprecht, 2011). Particular emphasis should be given to ge-
netic typing technologies that have been shown to be very infor-
mative to assess the impact of control and prevention strategies on
the elimination of dog-maintained RABLV lineages. Typing is also
essential for the early detection of imported dog-maintained and
dog-derived RABLV variants, the characterization and distribution
of variants established in wildlife (mainly terrestrial meso-
carnivores and bats) and the detection of novel RABLV linked to therise of new potential reservoir hosts (Smith, 1989 and Smith et al.,
1992; Velasco-Villa et al., 2008).
Genetic typing has not yet been fully implemented across Latin
America. Adequate sampling will be critical to obtain reliable in-
formation on elimination status and monitoring of emerging rabies
public health threats. Robust genetic typing results obtained
through adequate sampling should encompass year-round and
geographically comprehensive monitoring of:
 all rabid dogs in regions where dog-maintained rabies has
become rare;
 all outbreaks in mesocarnivores in countries or regions where
dog-maintained rabies has been enzootic for decades;
 recurrent routbreaks in mesocarnivores where bat-maintained
rabies is common or has not previously been detected;
 recurrent outbreaks in livestock in regions where vampire bat-
transmitted rabies is not common; and
 all dead bats encountered in peri-domestic areas.
Government-run animal control units play a critical role in
rabies surveillance in Latin America, because they are the main
providers of samples tested by diagnostic laboratories in the long-
term monitoring of free-roaming dogs and wildlife. They also
participate in vaccination of dogs on a daily basis and during mass
vaccination campaigns. They also participate in the removal of stray
dogs from public places, the quarantine of dogs that have bitten
humans, and euthanasia of suspect rabid animals to obtain central
nervous system samples for testing. Animal control units also
perform on-site spaying and neutering of dogs and cats, and they
may also serve as adoption centers (Lucas et al., 2008; National
Association of State Public Health Veterinarians Committee,
2008). These units are subsidized by local governments, and
either provide most services free of charge or charge low, symbolic
fees.
11. Ecological challenges in the elimination of dog-
maintained and dog-derived RABLV
Dog-derived RABLV variants that have become established in
meso-carnivore populations of the Americas present serious chal-
lenges for the elimination of enzootic rabies in dogs and the sub-
sequent reduction of the rabies burden of humans (Fig. 2, Table 3). It
is clear that maintenance of thorough laboratory-based surveil-
lance (including genetic typing), coupled with ideal herd immunity
(above 70% of the total population) and lowered free-ranging dog
population densities are key elements in preventing the return of
enzootic dog-derived variants into the dog population (Figs. 3 and
4) (PAHO, 2010; Wandeler et al., 1988).
Cuba, Puerto Rico, the Dominican Republic and Haiti in the
Caribbean region present special illustrations of the latter concern,
as dog and mongoose populations maintain the same dog-derived
RABLV variant (Fig. 3) (Nadin-Davis et al., 2006, 2008). High
reproductive rates of both animal species and low vaccination
coverage in free-roaming dogs make it difﬁcult to achieve the
needed levels of herd immunity to deﬁnitively eliminate rabies
from both the dog and mongoose populations (Figs. 2 and 3). A
customized plan of action will be required to simultaneously target
both species for sustained disruption of the maintenance cycle. In
this particular case, because both vulnerable populations are free-
roaming, the implementation of an oral vaccination program for
both dogs and mongooses may be the only feasible means of
eradicating dog-derived RABLV variants from these island
countries.
A more recent instance of a dog-derived variant returning to a
dog populationwith low herd immunity due to inadequate vaccine
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border. A dog-derived coyote RABLV variant was ﬁrst detected in
southern Texas along the USA-Mexico border in 1988 (CDC, 1995),
but retrospective studies showed that it was actually circulating in
the 1970s (Velasco-Villa et al., 2008). An oral vaccination program
implemented in Texas in 1995 contributed to a dramatic reduction
in its circulation in coyotes by 2004 (Sidwa et al., 2005), and its
eventual elimination fromUSA dog and coyote populations by 2007
(Slate et al., 2009). The virus was also thought to have been elim-
inated from dogs in northeastern Mexico, but in fact it continued to
circulate in the coyote population, and was reintroduced into dogs
through coyote-dog contact. The 2011 re-introduction makes it
clear that long-term efforts will be needed to eliminate this dog-
derived variant from the coyote population. Latin American coun-
tries may beneﬁt from instituting similar oral rabies vaccination
programs in wildlife, especially to prevent the re-introduction of
dog-derived variants into dog populations (Fig. 3).
12. Conclusions
The dramatic decrease in the incidence of dog-maintained
rabies in the Western Hemisphere over the past decade and its
reduction in humans to almost zeromay tend to create a false sense
of security in public health ofﬁcials and governments, to the point
that canine rabies may no longer be considered a public health
problem, leading to budget cuts or the eventual elimination of
strategic national control activities. The danger with this notion is
that there is a constant threat for epizootics to re-occur, so as long
as dog-maintained rabies “hot spots” are still present and when-
ever free-roaming dog populations remain large, herd immunity
becomes low and dog-derived variants continue to circulate in
close proximity to naïve dog populations.
The elimination of canine rabies from the Western Hemisphere
will only be feasible if both dog-maintained and dog-derived RABLV
lineages and variants are permanently eliminated, particularly in
settings in which dog-maintained viruses are equally ﬁt to be
maintained by wildlife, as is the case of dog/mongoose rabies in the
Caribbean. However, canine rabies elimination may be possible by
keeping dog herd immunity above 70% at all times, fostering sus-
tained laboratory-based surveillance through reliable diagnosis
and RABLV genetic typing in dogs, domestic animals and wildlife
(terrestrial mesocarnivores and bats), and continuing to educate
the public on the risk of rabies transmission, prevention methods
and responsible pet ownership. The complete elimination of canine
rabies, especially in “hot spots,” requires permanent funding, with
governments and people committed to bringing resources and
elimination activities to those remote localities where the problem
persists.
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